Niagen Bioscience, Inc. (NAGE) Gross margin 2017–2025
Niagen Bioscience, Inc. (NAGE) gross margin by fiscal year — reported gross profit divided by reported revenue.
64.3%FY2025 · since FY2017: 49.4% → 64.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 64.3% | +2.4 pp |
| FY2024 | 61.8% | +1.1 pp |
| FY2023 | 60.8% | +1.4 pp |
| FY2022 | 59.4% | -2.1 pp |
| FY2021 | 61.5% | +2.0 pp |
| FY2020 | 59.5% | +3.9 pp |
| FY2019 | 55.7% | +4.8 pp |
| FY2018 | 50.9% | +1.5 pp |
| FY2017 | 49.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice